Hydroxyurea for treatment of unresectable meningiomas [4]

Lancet

Volumn 348, Issue 9031, 1996, Pages 888-889

  Schrell, U M H ^a   Rittig, M G ^a   Koch, U ^a   Marschalek, R ^a   Anders, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ADULT; CASE REPORT; CAVERNOUS SINUS; CLINICAL TRIAL; FEMALE; HUMAN; LETTER; MALE; MENINGIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029783717     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64757-5     Document Type: Letter

References (5)

1. SM Marks HL Whitewell RH Lye Recurrence of meningiomas after operation Surg Neurol 25 1986 436 440
2. E Knosp A Perneczky WT Koos G Fries C Matula Meningiomas of the space of the cavernous sinus Neurosurgery 38 1996 434 444
3. MB Wilson Meningiomas, genetics, malignancy, and the role of radiation in induction and treatment J Neurosurg 81 1994 666 675
4. LD Lunsford Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal? J Neurosurg 80 1994 187 190
5. UMH Schrell MG Rittig F Kiesewetter E Adams M Anders Hydroxyurea is a powerful inhibitor of meningioma cell growth. Evidence that hydroxyurea induces apoptosis in cultured meningioma cells and nude mice meningioma transplants Zentralbl Neurochir Suppl 1996 1996 (Abstract)